Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6008)
All Articles published online
|
Publishing Process of This Article
|
Mar 6, 2021 (publication date) through Jan 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lu J, Xie ZY, Zhu DH, Li LJ. Human menstrual blood-derived stem cells as immunoregulatory therapy in COVID-19: A case report and review of the literature. World J Clin Cases 2021; 9(7): 1705-1713 [PMID: 33728315 DOI: 10.12998/wjcc.v9.i7.1705] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i7/1705.htm |
| Number | Citing Articles |
| 1 |
Wenchun Qu, Zhen Wang, Erica Engelberg-Cook, Abu Bakar Siddik, Guojun Bu, Julie G. Allickson, Eva Kubrova, Arnold I. Caplan, Joshua M. Hare, Camillo Ricordi, Carl J. Pepine, Joanne Kurtzberg, Jorge M. Pascual, Jorge M. Mallea, Ricardo L. Rodriguez, Tarek Nayfeh, Samer Saadi, Elaine M. Richards, Keith March, Fred P. Sanfilippo. Effectiveness and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3924851
|
| 2 |
Gabriele Zanirati, Laura Provenzi, Lucas Lobraico Libermann, Sabrina Comin Bizotto, Isadora Machado Ghilardi, Daniel Rodrigo Marinowic, Ashok K. Shetty, Jaderson Costa Da Costa. Stem cell-based therapy for COVID-19 and ARDS: a systematic review. npj Regenerative Medicine 2021; 6(1) doi: 10.1038/s41536-021-00181-9
|
| 3 |
Lisa Chadha, Geetika Kashyap, Swapnil Rahane. Menstrual Blood Stem Cell Banking: Blessings in Disguise. Journal of Medical Evidence 2024; 5(3): 238 doi: 10.4103/JME.JME_19_24
|
| 4 |
Wenchun Qu, Zhen Wang, Erica Engelberg-Cook, Dan Yan, Abu Bakar Siddik, Guojun Bu, Julie G Allickson, Eva Kubrova, Arnold I Caplan, Joshua M Hare, Camillo Ricordi, Carl J Pepine, Joanne Kurtzberg, Jorge M Pascual, Jorge M Mallea, Ricardo L Rodriguez, Tarek Nayfeh, Samer Saadi, Ravindra V Durvasula, Elaine M Richards, Keith March, Fred P Sanfilippo. Efficacy and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis. Stem Cells Translational Medicine 2022; 11(7): 688 doi: 10.1093/stcltm/szac032
|
| 5 |
Dragan Primorac, Martin Čemerin, Vid Matišić, Vilim Molnar, Marko Strbad, Lenart Girandon, Lucija Zenić, Miomir Knežević, Stephen Minger, Denis Polančec. Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment. Pharmaceutics 2021; 13(9): 1481 doi: 10.3390/pharmaceutics13091481
|
| 6 |
Andrew Cao, Daniel Jeyaraj, Henry Liu. Co-Administration of Menstrual Blood-Derived Stem Cells and Remdesivir for the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Induced Pneumonia: A Research Protocol. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal 2022; 6(3): 1 doi: 10.26685/urncst.319
|
| 7 |
Fezzeh Heidari, Reza Heidari, Mehrdad Nasrollahzadeh Sabet, Amir Ali Hamidieh, Zohreh Saltanatpour. Menstrual Blood-Derived Mesenchymal Stem Cell Therapy for Severe
COVID-19 Patients. Current Stem Cell Research & Therapy 2024; 19(5): 644 doi: 10.2174/1574888X18666230417085117
|